MENU
KNSA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kiniksa Pharmaceuticals International (KNSA) Ownership - Who owns Kiniksa Pharmaceuticals International?
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
2 Church Street
Phone
+44 8081896257
Employees
297
Web
https://www.kiniksa.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.41B
P/E Ratio
164.54
Total Cash
243.63M
Projected Growth
N/A
Total Debt
9.86M
Revenue
423.24M
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash/Share
3.35
Total Debt/Equity
N/A
Revenue/Share
5.93 USD as % of share price
Fundamentals
KNSA
Capitalization
1.41B
P/E Ratio
164.54
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash
244M
Total Cash/Share
3.35
Total Debt
9.86M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.93%
Revenue
423M
ROE
N/A
Book Value
438M
P/B Ratio
3.36
Cash Flow
N/A
Earnings
-0.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
20K
Current Ratio
3.30
Current Revenue Per Employee
389003.20
Dividends Per Share - Security
N/A
EBITDA
-43.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
150.78
Revenue To Assets
-7.80
Shares Held By Institutions
1.05B
Shares Outstanding - Current
72.6M
Total Liabilities
142M
Total Volume MTD
N/A
Value
-1
Gain YTD
-1.517
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2 Church Street
Phone
+44 8081896257
Employees
297
Web
https://www.kiniksa.com